Construction and Evaluation of Guanylyl Cyclase C–Specific Antibody for Noninvasive Diagnosis and Targeted Therapy of Colorectal Cancer
Open Access
- 30 December 2025
- journal article
- Published by Society of Nuclear Medicine in Journal of Nuclear Medicine
- Vol. 67 (3) , 471-480
Abstract
Colorectal cancer (CRC) remains the leading cause of cancer mortality worldwide despite therapeutic advances. Guanylyl cyclase C (GUCY2C), an intestinal epithelial receptor, is emerging as a promising diagnostic and therapeutic target for CRC. Thus, we are interested in developing a monoclonal antibody probe targeting GUCY2C for both in vitro and in vivo diagnosis and treatment of CRC. Methods: The GUCY2C-specific monoclonal antibody, PR15-7, was generated by hybridoma fusion. We developed [89Zr]Zr-DFO-PR15-7 for PET imaging, Cy5-PR15-7 for near-infrared fluorescence I (NIR-I) detection, and ICG-PR15-7 for NIR-II–guided surgical navigation. The therapeutic potential was evaluated using [177Lu]Lu-DOTA-PR15-7 for targeted radiotherapy. Biologic properties and antitumor activity of PR15-7 probes were evaluated in vitro and in vivo. Results: PR15-7 showed strong GUCY2C binding affinity and tumor selectivity. PR15-7 probes in antibody-based PET and NIR imaging revealed 3 times higher signal intensity in GUCY2C-positive tumors compared with controls. The NIR-II probe ICG-PR15-7 enabled precise intraoperative tumor visualization and complete resection in orthotopic models. Therapeutic administration of [177Lu]Lu-DOTA-PR15-7 significantly inhibited tumor growth, with standardized tumor volumes at 16 d being markedly smaller than those in the control groups. Conclusion: We have established both optical and radionuclide probes with PR15-7 as a versatile therapeutic strategy, providing valuable insights into targeted therapy for CRC. Visual AbstractKeywords
This publication has 39 references indexed in Scilit:
- Intraoperative Resection Guidance and Rapid Pathological Diagnosis of Osteosarcoma using B7H3 Targeted Probe under NIR‐II Fluorescence ImagingAdvanced Science, 2024
- Targeting Claudin 18.2 Using a Highly Specific Antibody Enables Cancer Diagnosis and Guided SurgeryMolecular Pharmaceutics, 2022
- Diagnosis and Treatment of Metastatic Colorectal CancerJAMA, 2021
- Nano Codelivery of Oxaliplatin and Folinic Acid Achieves Synergistic Chemo-Immunotherapy with 5-Fluorouracil for Colorectal Cancer and Liver MetastasisACS Nano, 2020
- ImmunoPET: Concept, Design, and ApplicationsChemical Reviews, 2020
- Imaging PD-L1 Expression with ImmunoPETBioconjugate Chemistry, 2017
- GUCY2C: at the intersection of obesity and cancerTrends in Endocrinology & Metabolism, 2013
- PET imaging with 89Zr: From radiochemistry to the clinicNuclear Medicine and Biology, 2013
- Integrating noninvasive molecular imaging into molecular medicine: an evolving paradigmTrends in Molecular Medicine, 2007
- Expression of Guanylin Is Downregulated in Mouse and Human Intestinal AdenomasBiochemical and Biophysical Research Communications, 2000